CHM and choroideremia: Moreover, a recent novel clinical trial with the title “Retinal Gene Therapy for Choroideremia Using an Adeno-associated Viral Vector (AAV2) Encoding Rab-escort Protein-1 (REP1)” has been submitted to ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT02077361).